PRIMECAP MANAGEMENT CO/CA/

Position in IMCR — Immunocore Holdings plc

CIK 763212 PASADENA, CA

Position in IMCR

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$111,351,216

-$26,165,638 QoQ

Shares Held

3,693,241

-6.8% QoQ

Ownership

7.26%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.24971048463938.ToString("F0")% Shared 0.ToString("F0")% None 0.7502895153606277.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRIMECAP MANAGEMENT CO/CA/ holds $3,436,828,710 across 16 Biotechnology names. IMCR ranks #6 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	4,975,181	$1,477,479,501
2	BMRN	Biomarin Pharmaceutical Inc	14,194,005	$801,819,342
3	BNTX	BioNTech SE	3,793,711	$337,185,033
4	RYTM	Rhythm Pharmaceuticals, Inc.	3,417,509	$297,220,757
5	XNCR	Xencor Inc	10,338,022	$124,676,545
6	IMCR	Immunocore Holdings plc This page	3,693,241	$111,351,216
7	IMNM	Immunome Inc.	4,788,231	$104,718,611
8	BBIO	BridgeBio Pharma, Inc.	569,180	$42,267,306

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$111,351,216	3,693,241	-6.8%	Shares	Sole	2026-05-11
2025-12-31	$137,516,854	3,961,880	+5.5%	Shares	Sole	2026-02-11
2025-09-30	$136,403,164	3,754,560	-0.4%	Shares	Sole	2025-11-12
2025-06-30	$118,348,854	3,771,474	+40.8%	Shares	Sole	2025-08-11
2025-03-31	$79,475,545	2,678,650	+0.4%	Shares	Sole	2025-05-09
2024-12-31	$78,722,225	2,668,550	+8.0%	Shares	Sole	2025-02-10
2024-09-30	$76,953,982	2,472,020	+26.7%	Shares	Sole	2024-11-08
2024-06-30	$66,121,762	1,951,070	+3841.6%	Shares	Sole	2024-08-09
2024-03-31	$3,217,500	49,500	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.